Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2025-12-25 @ 9:59 PM
Study NCT ID:
NCT03565458
Status:
UNKNOWN
Last Update Posted:
2018-06-21
First Post:
2018-05-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Gemigliptin, Dapagliflozin, Empagliflozin DDI Study
Sponsor:
LG Chem
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LG-DPCL018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None